Screening Hesitancy of a Universal Voluntary-based Rapid Antigen Test for coronavirus disease 2019 (COVID-19) During Omicron Wave in Hong Kong

[1]  Kwang Su Kim,et al.  Designing isolation guidelines for COVID-19 patients with rapid antigen tests , 2022, Nature Communications.

[2]  A. Gesierich,et al.  Virus variant–specific clinical performance of SARS coronavirus two rapid antigen tests in point-of-care use, from November 2020 to January 2022 , 2022, Clinical Microbiology and Infection.

[3]  E. Yeoh,et al.  COVID-19 Vaccine Willingness and Related Factors Among Health Care Workers in 3 Southeast Asian Jurisdictions , 2022, JAMA network open.

[4]  K. Bond,et al.  Utility of SARS-CoV-2 rapid antigen testing for patient triage in the emergency department: A clinical implementation study in Melbourne, Australia , 2022, The Lancet Regional Health - Western Pacific.

[5]  B. Cowling,et al.  Public acceptability of COVID-19 control measures in Singapore, Hong Kong, and Malaysia: A cross-sectional survey , 2022, International Journal of Infectious Diseases.

[6]  Luke Taylor.  Covid-19: Hong Kong reports world’s highest death rate as zero covid strategy fails , 2022, BMJ.

[7]  A. Haque,et al.  Mitigating Covid-19 in the face of emerging virus variants, breakthrough infections and vaccine hesitancy , 2022, Journal of Autoimmunity.

[8]  E. Yeoh,et al.  COVID-19 Vaccine Hesitancy in a City with Free Choice and Sufficient Doses , 2021, Vaccines.

[9]  D. Walt,et al.  An Assessment of a Rapid SARS-CoV-2 Antigen Test in Bangladesh , 2021, medRxiv.

[10]  D. Ausserhofer,et al.  Rapid antigen test to identify COVID-19 infected patients with and without symptoms admitted to the Emergency Department , 2021, The American Journal of Emergency Medicine.

[11]  Katelyn A. Reed,et al.  Evaluation of the BinaxNOW COVID-19 Rapid Antigen Test in an Asymptomatic Patient Population Undergoing Preprocedural Screening , 2021, Journal of clinical microbiology.

[12]  Victor Zheng,et al.  Using a dual-frame design to improve phone surveys on political attitudes: developing a weighting strategy for limited external information in Hong Kong , 2021, Quality & Quantity.

[13]  H. Larson,et al.  Public Attitudes and Factors of COVID-19 Testing Hesitancy in the United Kingdom and China: Comparative Infodemiology Study , 2021, JMIR infodemiology.

[14]  C. Denkinger,et al.  Rapid comparative evaluation of SARS-CoV-2 rapid point-of-care antigen tests , 2021, Infection.

[15]  P. Ahmad-Nejad,et al.  Diagnostic Performance of SARS-CoV-2 Rapid Antigen Test in a Large, German Cohort , 2021, Children.

[16]  E. Bonner,et al.  Evaluation of the AMP SARS-CoV-2 rapid antigen test in a hospital setting , 2021, International Journal of Infectious Diseases.

[17]  M. Suhrcke,et al.  How to make universal, voluntary testing for COVID-19 work? A behavioural economics perspective , 2021, Health Policy.

[18]  Y. Akashi,et al.  The evaluation of a novel digital immunochromatographic assay with silver amplification to detect SARS-CoV-2 , 2021, Journal of Infection and Chemotherapy.

[19]  J. Mingorance,et al.  Think of the Children , 2021, Pediatric Infectious Disease Journal.

[20]  K. Gibney,et al.  Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: A validation and implementation study , 2021, The Lancet Regional Health - Western Pacific.

[21]  J. Tate,et al.  Evaluation of Abbott BinaxNOW Rapid Antigen Test for SARS-CoV-2 Infection at Two Community-Based Testing Sites — Pima County, Arizona, November 3–17, 2020 , 2021, MMWR. Morbidity and mortality weekly report.

[22]  Zigui Chen,et al.  Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong , 2021, Vaccine.

[23]  S. Wong,et al.  Change of Willingness to Accept COVID-19 Vaccine and Reasons of Vaccine Hesitancy of Working People at Different Waves of Local Epidemic in Hong Kong, China: Repeated Cross-Sectional Surveys , 2021, Vaccines.

[24]  S. Stillman,et al.  Communities and testing for COVID-19 , 2020, The European Journal of Health Economics.

[25]  D. Raoult,et al.  Evaluation of the Panbio COVID-19 Rapid Antigen Detection Test Device for the Screening of Patients with COVID-19 , 2020, Journal of Clinical Microbiology.

[26]  A. Pollard,et al.  What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2 , 2020, The Lancet Infectious Diseases.

[27]  Naomi R. Waterlow,et al.  Quarantine and testing strategies in contact tracing for SARS-CoV-2: a modelling study , 2020, The Lancet Public Health.

[28]  A. Raffle,et al.  Covid-19 mass testing programmes , 2020, BMJ.

[29]  J. Shogren,et al.  Testing for COVID-19: willful ignorance or selfless behavior? , 2020, Behavioural Public Policy.

[30]  Julian Peto,et al.  Covid-19 mass testing facilities could end the epidemic rapidly , 2020, BMJ.

[31]  Chris J. Skinner,et al.  Estimation in dual frame surveys with complex designs , 1996 .

[32]  Mahmoud Elkasabi.  Weighting Procedures for Dual Frame Telephone Surveys: A Case Study in Egypt , 2014 .